Approaches to neural tissue engineering using scaffolds for drug delivery

Advanced Drug Delivery Reviews

Volumn 59, Issue 4-5, 2007, Pages 325-338

  Willerth, Stephanie M ^a   Sakiyama Elbert, Shelly E ^a,b  

^a WASHINGTON UNIVERSITY IN ST LOUIS   (United States)

^b WASHINGTON UNIVERSITY   (United States)

Author keywords

Controlled release; Neurotrophins; Polymers; Regenerative medicine

Indexed keywords

CELL IMMOBILIZATION; DRUG DELIVERY; DRUG PRODUCTS; ORGANIC POLYMERS; SCAFFOLDS;

CONTROLLED RELEASE; NEUROTROPHINS; REGENERATIVE MEDICINE;

TISSUE ENGINEERING;

ACIDIC FIBROBLAST GROWTH FACTOR; AGAROSE; ALGINIC ACID; ALPHA INTERMEDIN; BASIC FIBROBLAST GROWTH FACTOR; BRAIN DERIVED NEUROTROPHIC FACTOR; CHITOSAN; CILIARY NEUROTROPHIC FACTOR; COLLAGEN; DEXAMETHASONE; DEXTRAN; ETHYLENE VINYL ACETATE COPOLYMER; FIBRIN; FIBRONECTIN; GLIAL CELL LINE DERIVED NEUROTROPHIC FACTOR; HYALURONIC ACID; MACROGOL; METHYLCELLULOSE; NERVE GROWTH FACTOR; NEUROTROPHIN 3; NEUROTROPHIN 4; POLYGLACTIN; POLYMACON; POLYPYRROLE; PYROXYLIN; TRANSFORMING GROWTH FACTOR BETA;

ALZHEIMER DISEASE; ARTHRITIS; BINDING AFFINITY; BRAIN TISSUE; CONTROLLED DRUG RELEASE; DRUG DELIVERY SYSTEM; ELECTRICITY; HUMAN; HUNTINGTON CHOREA; MULTIPLE SCLEROSIS; NERVOUS TISSUE; NONHUMAN; PERIPHERAL NERVE; PRIORITY JOURNAL; REVIEW; SPINAL CORD; SPINAL CORD INJURY; TISSUE ENGINEERING; TISSUE REPAIR;

BIOCOMPATIBLE MATERIALS; BRAIN INJURIES; DRUG DELIVERY SYSTEMS; HUMANS; INTERCELLULAR SIGNALING PEPTIDES AND PROTEINS; MICROSPHERES; NERVE GROWTH FACTORS; PERIPHERAL NERVES; REGENERATION; SPINAL CORD INJURIES; TISSUE ENGINEERING;

EID: 34249951852     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.addr.2007.03.014     Document Type: Review

References (140)

1. Sosin D.M., Sniezek J.E., and Thurman D.J. Incidence of mild and moderate brain injury in the United States, 1991. Brain Inj. 10 1 (1996) 47-54
2. Hebert L.E., Scherr P.A., Bienias J.L., Bennett D.A., and Evans D.A. Alzheimer disease in the US population: prevalence estimates using the 2000 census. Arch. Neurol. 60 8 (2003) 1119-1122
3. Fact Sheet about Parkinson's Disease: Parkinson's Disease Foundation 2006.
4. National Spinal Cord Injury Statistical Center Fact Sheet.: National Spinal Cord Injury Center June 2006.
5. Noble J., Munro C.A., Prasad V.S., and Midha R. Analysis of upper and lower extremity peripheral nerve injuries in a population of patients with multiple injuries. J. Trauma 45 1 (1998) 116-122
6. Archibald S.J., Krarup C., Shefner J., Li S.T., and Madison R.D. A collagen-based nerve guide conduit for peripheral nerve repair: an electrophysiological study of nerve regeneration in rodents and nonhuman primates. J. Comp. Neurol. 306 4 (1991) 685-696
7. Alcantar N.A., Aydil E.S., and Israelachvili J.N. Polyethylene glycol-coated biocompatible surfaces. J. Biomed. Mater. Res. 51 3 (2000) 343-351
8. Elbert D.L., and Hubbell J.A. Conjugate addition reactions combined with free-radical cross-linking for the design of materials for tissue engineering. Biomacromolecules 2 2 (2001) 430-441
9. Peppas N.A., Keys K.B., Torres-Lugo M., and Lowman A.M. Poly(ethylene glycol)-containing hydrogels in drug delivery. J. Control. Release 62 1-2 (1999) 81-87
10. Nguyen K.T., and West J.L. Photopolymerizable hydrogels for tissue engineering applications. Biomaterials 23 22 (2002) 4307-4314
11. Burdick J.A., Ward M., Liang E., Young M.J., and Langer R. Stimulation of neurite outgrowth by neurotrophins delivered from degradable hydrogels. Biomaterials 27 3 (2006) 452-459
12. Piantino J., Burdick J.A., Goldberg D., Langer R., and Benowitz L.I. An injectable, biodegradable hydrogel for trophic factor delivery enhances axonal rewiring and improves performance after spinal cord injury. Exp. Neurol. 201 2 (2006) 359-367. • This paper characterized controlled release of NT-3 in vitro and in vivo and demonstrated that scaffolds for drug delivery can promoted functional recovery in SCI.
13. Elbert D.L., Pratt A.B., Lutolf M.P., Halstenberg S., and Hubbell J.A. Protein delivery from materials formed by self-selective conjugate addition reactions. J. Control. Release 76 1-2 (2001) 11-25
14. Groll J., Fiedler J., Engelhard E., Ameringer T., Tugulu S., Klok H.A., Brenner R.E., and Moeller M. A novel star PEG-derived surface coating for specific cell adhesion. J. Biomed. Mater. Res. A 74 4 (2005) 607-617
15. Benoit D.S., and Anseth K.S. Heparin functionalized PEG gels that modulate protein adsorption for hMSC adhesion and differentiation. Acta Biomater. 1 4 (2005) 461-470
16. Tae G., Scatena M., Stayton P.S., and Hoffman A.S. PEG-cross-linked heparin is an affinity hydrogel for sustained release of vascular endothelial growth factor. J. Biomater. Sci., Polym. Ed. 17 1-2 (2006) 187-197
17. During M.J., Freese A., Sabel B.A., Saltzman W.M., Deutch A., Roth R.H., and Langer R. Controlled release of dopamine from a polymeric brain implant: in vivo characterization. Ann. Neurol. 25 4 (1989) 351-356
18. Freese A., Sabel B.A., Saltzman W.M., During M.J., and Langer R. Controlled release of dopamine from a polymeric brain implant: in vitro characterization. Exp. Neurol. 103 3 (1989) 234-238
19. Krewson C.E., Klarman M.L., and Saltzman W.M. Distribution of nerve growth factor following direct delivery to brain interstitium. Brain Res. 680 1-2 (1995) 196-206
20. Krewson C.E., and Saltzman W.M. Transport and elimination of recombinant human NGF during long-term delivery to the brain. Brain Res. 727 1-2 (1996) 169-181
21. Mahoney M.J., and Saltzman W.M. Millimeter-scale positioning of a nerve-growth-factor source and biological activity in the brain. Proc. Natl. Acad. Sci. U. S. A. 96 8 (1999) 4536-4539. • This paper defined the minimum distance NGF releasing microspheres needed to be implanted to have an effect on target cells. It also proposed a method for delivering NGF to large irregularly shaped volumes inside the brain based on mathematical modeling the gradients created by the implants.
22. Powell E.M., Sobarzo M.R., and Saltzman W.M. Controlled release of nerve growth factor from a polymeric implant. Brain Res. 515 1-2 (1990) 309-311
23. Saltzman W.M., Mak M.W., Mahoney M.J., Duenas E.T., and Cleland J.L. Intracranial delivery of recombinant nerve growth factor: release kinetics and protein distribution for three delivery systems. Pharm. Res. 16 2 (1999) 232-240
24. Barras F.M., Pasche P., Bouche N., Aebischer P., and Zurn A.D. Glial cell line-derived neurotrophic factor released by synthetic guidance channels promotes facial nerve regeneration in the rat. J. Neurosci. Res. 70 6 (2002) 746-755
25. Hoffman D., Wahlberg L., and Aebischer P. NGF released from a polymer matrix prevents loss of ChAT expression in basal forebrain neurons following a fimbria-fornix lesion. Exp. Neurol. 110 1 (1990) 39-44
26. Bloch J., Fine E.G., Bouche N., Zurn A.D., and Aebischer P. Nerve growth factor- and neurotrophin-3-releasing guidance channels promote regeneration of the transected rat dorsal root. Exp. Neurol. 172 2 (2001) 425-432
27. Fine E.G., Decosterd I., Papaloizos M., Zurn A.D., and Aebischer P. GDNF and NGF released by synthetic guidance channels support sciatic nerve regeneration across a long gap. Eur. J. Neurosci. 15 4 (2002) 589-601
28. Athanasiou K.A., Niederauer G.G., and Agrawal C.M. Sterilization, toxicity, biocompatibility and clinical applications of polylactic acid/polyglycolic acid copolymers. Biomaterials 17 2 (1996) 93-102
29. Gunatillake P.A., and Adhikari R. Biodegradable synthetic polymers for tissue engineering. Eur. Cell Mater. 5 (2003) 1-16 (discussion 16)
30. Nomura H., Tator C.H., and Shoichet M.S. Bioengineered strategies for spinal cord repair. J. Neurotrauma 23 3-4 (2006) 496-507
31. Nomura H., Katayama Y., Shoichet M.S., and Tator C.H. Complete spinal cord transection treated by implantation of a reinforced synthetic hydrogel channel results in syringomyelia and caudal migration of the rostral stump. Neurosurgery 59 1 (2006) 183-192 (discussion 183-92)
32. Tsai E.C., Dalton P.D., Shoichet M.S., and Tator C.H. Matrix inclusion within synthetic hydrogel guidance channels improves specific supraspinal and local axonal regeneration after complete spinal cord transection. Biomaterials 27 3 (2006) 519-533
33. Tsai E.C., Dalton P.D., Shoichet M.S., and Tator C.H. Synthetic hydrogel guidance channels facilitate regeneration of adult rat brainstem motor axons after complete spinal cord transection. J. Neurotrauma 21 6 (2004) 789-804
34. Carone T.W., and Hasenwinkel J.M. Mechanical and morphological characterization of homogeneous and bilayered poly(2-hydroxyethyl methacrylate) scaffolds for use in CNS nerve regeneration. J. Biomed. Mater. Res. B. Appl. Biomater. 78 2 (2006) 274-282
35. Masuda H., and Asano D.K. Preparation and properties of polypyrrole. Synth. Met. 135-6 (2003) 43-44
36. George P.M., Lyckman A.W., LaVan D.A., Hegde A., Leung Y., Avasare R., Testa C., Alexander P.M., Langer R., and Sur M. Fabrication and biocompatibility of polypyrrole implants suitable for neural prosthetics. Biomaterials 26 17 (2005) 3511-3519
37. Wang X., Gu X., Yuan C., Chen S., Zhang P., Zhang T., Yao J., Chen F., and Chen G. Evaluation of biocompatibility of polypyrrole in vitro and in vivo. J. Biomed. Mater. Res. A. 68 3 (2004) 411-422
38. Gomez N., and Schmidt C.E. Nerve growth factor-immobilized polypyrrole: bioactive electrically conducting polymer for enhanced neurite extension. J. Biomed. Mater. Res. A. (2006)
39. Richardson R.T., Thompson B., Moulton S., Newbold C., Lum M.G., Cameron A., Wallace G., Kapsa R., Clark G., and O'Leary S. The effect of polypyrrole with incorporated neurotrophin-3 on the promotion of neurite outgrowth from auditory neurons. Biomaterials 28 3 (2007) 513-523
40. Wadhwa R., Lagenaur C.F., and Cui X.T. Electrochemically controlled release of dexamethasone from conducting polymer polypyrrole coated electrode. J. Control. Release 110 3 (2006) 531-541. • This paper utilized the electrical currents delivered by neural implants to create controlled release of a model anti-inflammatory drug.
41. Thompson B.C., Moulton S.E., Ding J., Richardson R., Cameron A., O'Leary S., Wallace G.G., and Clark G.M. Optimising the incorporation and release of a neurotrophic factor using conducting polypyrrole. J. Control. Release 116 2 (2006) 285-294
42. Balgude A.P., Yu X., Szymanski A., and Bellamkonda R.V. Agarose gel stiffness determines rate of DRG neurite extension in 3D cultures. Biomaterials 22 10 (2001) 1077-1084
43. Bellamkonda R., Ranieri J.P., Bouche N., and Aebischer P. Hydrogel-based three-dimensional matrix for neural cells. J. Biomed. Mater. Res. 29 5 (1995) 663-671
44. Cao X., and Shoichet M.S. Defining the concentration gradient of nerve growth factor for guided neurite outgrowth. Neuroscience 103 3 (2001) 831-840
45. Dillon G.P., Yu X., Sridharan A., Ranieri J.P., and Bellamkonda R.V. The influence of physical structure and charge on neurite extension in a 3D hydrogel scaffold. J. Biomater. Sci., Polym. Ed. 9 10 (1998) 1049-1069
46. Jain A., Kim Y.T., McKeon R.J., and Bellamkonda R.V. In situ gelling hydrogels for conformal repair of spinal cord defects, and local delivery of BDNF after spinal cord injury. Biomaterials 27 3 (2006) 497-504
47. Kataoka K., Suzuki Y., Kitada M., Hashimoto T., Chou H., Bai H., Ohta M., Wu S., Suzuki K., and Ide C. Alginate enhances elongation of early regenerating axons in spinal cord of young rats. Tissue Eng. 10 3-4 (2004) 493-504
48. Kataoka K., Suzuki Y., Kitada M., Ohnishi K., Suzuki K., Tanihara M., Ide C., Endo K., and Nishimura Y. Alginate, a bioresorbable material derived from brown seaweed, enhances elongation of amputated axons of spinal cord in infant rats. J. Biomed. Mater. Res. 54 3 (2001) 373-384
49. Maysinger D., Krieglstein K., Filipovic-Grcic J., Sendtner M., Unsicker K., and Richardson P. Microencapsulated ciliary neurotrophic factor: physical properties and biological activities. Exp. Neurol. 138 2 (1996) 177-188
50. Prang P., Muller R., Eljaouhari A., Heckmann K., Kunz W., Weber T., Faber C., Vroemen M., Bogdahn U., and Weidner N. The promotion of oriented axonal regrowth in the injured spinal cord by alginate-based anisotropic capillary hydrogels. Biomaterials 27 19 (2006) 3560-3569
51. Stabenfeldt S.E., Garcia A.J., and LaPlaca M.C. Thermoreversible laminin-functionalized hydrogel for neural tissue engineering. J. Biomed. Mater. Res. A. 77 4 (2006) 718-725
52. Tate M.C., Shear D.A., Hoffman S.W., Stein D.G., and LaPlaca M.C. Biocompatibility of methylcellulose-based constructs designed for intracerebral gelation following experimental traumatic brain injury. Biomaterials 22 10 (2001) 1113-1123
53. Zhong Y., and Bellamkonda R.V. Controlled release of anti-inflammatory agent alpha-MSH from neural implants. J. Control. Release 106 3 (2005) 309-318
54. Crompton K.E., Goud J.D., Bellamkonda R.V., Gengenbach T.R., Finkelstein D.I., Horne M.K., and Forsythe J.S. Polylysine-functionalised thermoresponsive chitosan hydrogel for neural tissue engineering. Biomaterials 28 3 (2007) 441-449
55. Freier T., Koh H.S., Kazazian K., and Shoichet M.S. Controlling cell adhesion and degradation of chitosan films by N-acetylation. Biomaterials 26 29 (2005) 5872-5878
56. Gamez E., Goto Y., Nagata K., Iwaki T., Sasaki T., and Matsuda T. Photofabricated gelatin-based nerve conduits: nerve tissue regeneration potentials. Cell Transplant 13 5 (2004) 549-564
57. Mahoney M.J., Krewson C., Miller J., and Saltzman W.M. Impact of cell type and density on nerve growth factor distribution and bioactivity in 3-dimensional collagen gel cultures. Tissue Eng. 12 7 (2006) 1915-1927
58. Wissink M.J., Beernink R., Pieper J.S., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., and Feijen J. Binding and release of basic fibroblast growth factor from heparinized collagen matrices. Biomaterials 22 16 (2001) 2291-2299
59. Wissink M.J., Beernink R., Pieper J.S., Poot A.A., Engbers G.H., Beugeling T., van Aken W.G., and Feijen J. Immobilization of heparin to EDC/NHS-crosslinked collagen. Characterization and in vitro evaluation. Biomaterials 22 2 (2001) 151-163
60. Massia S.P., Holecko M.M., and Ehteshami G.R. In vitro assessment of bioactive coatings for neural implant applications. J. Biomed. Mater. Res. A. 68 1 (2004) 177-186
61. C.L. Klaver, M.R. Caplan, Bioactive surface for neural electrodes: decreasing astrocyte proliferation via transforming growth factor beta-1, J. Biomed. Mater. Res. A. (in press).
62. Levesque S.G., and Shoichet M.S. Synthesis of cell-adhesive dextran hydrogels and macroporous scaffolds. Biomaterials 27 30 (2006) 5277-5285
63. Herbert C.B., Bittner G.D., and Hubbell J.A. Effects of fibinolysis on neurite growth from dorsal root ganglia cultured in two- and three-dimensional fibrin gels. J. Comp. Neurol. 365 3 (1996) 380-391
64. Sakiyama S.E., Schense J.C., and Hubbell J.A. Incorporation of heparin-binding peptides into fibrin gels enhances neurite extension: an example of designer matrices in tissue engineering. FASEB J. 13 15 (1999) 2214-2224
65. Sakiyama-Elbert S.E., and Hubbell J.A. Controlled release of nerve growth factor from a heparin-containing fibrin-based cell ingrowth matrix. J. Control. Release 69 1 (2000) 149-158. • This paper demonstrated that neurotrophins could be delivered from a heparin based delivery system incorporated into a fibrin scaffold.
66. Sakiyama-Elbert S.E., and Hubbell J.A. Development of fibrin derivatives for controlled release of heparin-binding growth factors. J. Control. Release 65 3 (2000) 389-402
67. Sakiyama-Elbert S.E., Panitch A., and Hubbell J.A. Development of growth factor fusion proteins for cell-triggered drug delivery. FASEB J. 15 7 (2001) 1300-1302
68. Schense J.C., and Hubbell J.A. Cross-linking exogenous bifunctional peptides into fibrin gels with factor XIIIa. Bioconjug Chem. 10 1 (1999) 75-81
69. Ahmed Z., Underwood S., and Brown R.A. Nerve guide material made from fibronectin: assessment of in vitro properties. Tissue Eng. 9 2 (2003) 219-231
70. Brown R.A., Blunn G.W., and Ejim O.S. Preparation of orientated fibrous mats from fibronectin: composition and stability. Biomaterials 15 6 (1994) 457-464
71. Ejim O.S., Blunn G.W., and Brown R.A. Production of artificial-orientated mats and strands from plasma fibronectin: a morphological study. Biomaterials 14 10 (1993) 743-748
72. King V.R., Henseler M., Brown R.A., and Priestley J.V. Mats made from fibronectin support oriented growth of axons in the damaged spinal cord of the adult rat. Exp. Neurol. 182 2 (2003) 383-398
73. King V.R., Phillips J.B., Hunt-Grubbe H., Brown R., and Priestley J.V. Characterization of non-neuronal elements within fibronectin mats implanted into the damaged adult rat spinal cord. Biomaterials 27 3 (2006) 485-496
74. Phillips J.B., King V.R., Ward Z., Porter R.A., Priestley J.V., and Brown R.A. Fluid shear in viscous fibronectin gels allows aggregation of fibrous materials for CNS tissue engineering. Biomaterials 25 14 (2004) 2769-2779
75. Gupta D., Tator C.H., and Shoichet M.S. Fast-gelling injectable blend of hyaluronan and methylcellulose for intrathecal, localized delivery to the injured spinal cord. Biomaterials 27 11 (2006) 2370-2379
76. Wiesmann C., and de Vos A.M. Nerve growth factor: structure and function. Cell. Mol. Life Sci. 58 5-6 (2001) 748-759
77. Huang E.J., and Reichardt L.F. Neurotrophins: roles in neuronal development and function. Annu. Rev. Neurosci. 24 (2001) 677-736
78. Siegel G.J., and Chauhan N.B. Neurotrophic factors in Alzheimer's and Parkinson's disease brain. Brain Res. Brain Res. Rev. 33 2-3 (2000) 199-227
79. Romero M.I., Rangappa N., Garry M.G., and Smith G.M. Functional regeneration of chronically injured sensory afferents into adult spinal cord after neurotrophin gene therapy. J. Neurosci. 21 21 (2001) 8408-8416
80. Grill R., Murai K., Blesch A., Gage F.H., and Tuszynski M.H. Cellular delivery of neurotrophin-3 promotes corticospinal axonal growth and partial functional recovery after spinal cord injury. J. Neurosci. 17 14 (1997) 5560-5572
81. Taylor S.J., McDonald III J.W., and Sakiyama-Elbert S.E. Controlled release of neurotrophin-3 from fibrin gels for spinal cord injury. J. Control. Release 98 2 (2004) 281-294
82. Taylor S.J., and Sakiyama-Elbert S.E. Effect of controlled delivery of neurotrophin-3 from fibrin on spinal cord injury in a long term model. J. Control. Release 116 2 (2006) 204-210
83. Taylor S.J., Rosenzweig E.S., McDonald III J.W., and Sakiyama-Elbert S.E. Delivery of neurotrophin-3 from fibrin enhances neuronal fiber sprouting after spinal cord injury. J. Control. Release 113 3 (2006) 226-235
84. Bramham C.R., and Messaoudi E. BDNF function in adult synaptic plasticity: the synaptic consolidation hypothesis. Prog. Neurobiol. 76 2 (2005) 99-125
85. Patist C.M., Mulder M.B., Gautier S.E., Maquet V., Jerome R., and Oudega M. Freeze-dried poly(d,l-lactic acid) macroporous guidance scaffolds impregnated with brain-derived neurotrophic factor in the transected adult rat thoracic spinal cord. Biomaterials 25 9 (2004) 1569-1582
86. Vergara C., and Ramirez B. CNTF, a pleiotropic cytokine: emphasis on its myotrophic role. Brain Res. Brain Res. Rev. 47 1-3 (2004) 161-173
87. Ishii K., Nakamura M., Dai H., Finn T.P., Okano H., Toyama Y., and Bregman B.S. Neutralization of ciliary neurotrophic factor reduces astrocyte production from transplanted neural stem cells and promotes regeneration of corticospinal tract fibers in spinal cord injury. J. Neurosci. Res. 84 8 (2006) 1669-1681
88. Grothe C., Haastert K., and Jungnickel J. Physiological function and putative therapeutic impact of the FGF-2 system in peripheral nerve regeneration-lessons from in vivo studies in mice and rats. Brain Res. Brain Res. Rev. 51 2 (2006) 293-299
89. Kim D.H., and Martin D.C. Sustained release of dexamethasone from hydrophilic matrices using PLGA nanoparticles for neural drug delivery. Biomaterials 27 15 (2006) 3031-3037
90. Ichiyama T., Campbell I.L., Furukawa S., Catania A., and Lipton J.M. Autocrine alpha-melanocyte-stimulating hormone inhibits NF-kappaB activation in human glioma. J. Neurosci. Res. 58 5 (1999) 684-689
91. Wells M.R., Kraus K., Batter D.K., Blunt D.G., Weremowitz J., Lynch S.E., Antoniades H.N., and Hansson H.A. Gel matrix vehicles for growth factor application in nerve gap injuries repaired with tubes: a comparison of biomatrix, collagen, and methylcellulose. Exp. Neurol. 146 2 (1997) 395-402
92. Yu X., and Bellamkonda R.V. Tissue-engineered scaffolds are effective alternatives to autografts for bridging peripheral nerve gaps. Tissue Eng. 9 3 (2003) 421-430
93. Houweling D.A., Lankhorst A.J., Gispen W.H., Bar P.R., and Joosten E.A. Collagen containing neurotrophin-3 (NT-3) attracts regrowing injured corticospinal axons in the adult rat spinal cord and promotes partial functional recovery. Exp. Neurol. 153 1 (1998) 49-59
94. Moore K., MacSween M., and Shoichet M. Immobilized concentration gradients of neurotrophic factors guide neurite outgrowth of primary neurons in macroporous scaffolds. Tissue Eng. 12 2 (2006) 267-278
95. Winter J.O., Cogan S.F., and Rizzo III J.F. Neurotrophin-eluting hydrogel coatings for neural stimulating electrodes. J. Biomed. Mater. Res. B. Appl. Biomater. 81 2 (2006) 551-563
96. Benoit J.P., Faisant N., Venier-Julienne M.C., and Menei P. Development of microspheres for neurological disorders: from basics to clinical applications. J. Control. Release 65 1-2 (2000) 285-296
97. Mahoney M.J., and Saltzman W.M. Controlled release of proteins to tissue transplants for the treatment of neurodegenerative disorders. J. Pharm. Sci. 85 12 (1996) 1276-1281
98. Lam X.M., Duenas E.T., and Cleland J.L. Encapsulation and stabilization of nerve growth factor into poly(lactic-co-glycolic) acid microspheres. J. Pharm. Sci. 90 9 (2001) 1356-1365
99. Aubert-Pouessel A., Venier-Julienne M.C., Clavreul A., Sergent M., Jollivet C., Montero-Menei C.N., Garcion E., Bibby D.C., Menei P., and Benoit J.P. In vitro study of GDNF release from biodegradable PLGA microspheres. J. Control. Release 95 3 (2004) 463-475
100. Rosner B.I., Siegel R.A., Grosberg A., and Tranquillo R.T. Rational design of contact guiding, neurotrophic matrices for peripheral nerve regeneration. Ann. Biomed. Eng. 31 11 (2003) 1383-1401
101. Yang Y., De Laporte L., Rives C.B., Jang J.H., Lin W.C., Shull K.R., and Shea L.D. Neurotrophin releasing single and multiple lumen nerve conduits. J. Control. Release 104 3 (2005) 433-446
102. Goraltchouk A., Scanga V., Morshead C.M., and Shoichet M.S. Incorporation of protein-eluting microspheres into biodegradable nerve guidance channels for controlled release. J. Control. Release 110 2 (2006) 400-407
103. Edelman E.R., Mathiowitz E., Langer R., and Klagsbrun M. Controlled and modulated release of basic fibroblast growth factor. Biomaterials 12 7 (1991) 619-626
104. Lee A.C., Yu V.M., Lowe III J.B., Brenner M.J., Hunter D.A., Mackinnon S.E., and Sakiyama-Elbert S.E. Controlled release of nerve growth factor enhances sciatic nerve regeneration. Exp. Neurol. 184 1 (2003) 295-303
105. Maxwell D.J., Hicks B.C., Parsons S., and Sakiyama-Elbert S.E. Development of rationally designed affinity-based drug delivery systems. Acta Biomater. 1 1 (2005) 101-113
106. Willerth S.M., Johnson P.J., Maxwell D.J., Parsons S.R., Doukas M.E., and Sakiyama-Elbert S.E. Rationally designed peptides for controlled release of nerve growth factor from fibrin matrices. J. Biomed. Mater. Res. A. (2006)
107. Kapur T.A., and Shoichet M.S. Chemically-bound nerve growth factor for neural tissue engineering applications. J. Biomater. Sci., Polym. Ed. 14 4 (2003) 383-394. • This paper describes how to use photochemistry to covalently incorporate NGF into scaffolds for drug delivery.
108. Gomez N., Lu Y., Chen S., and Schmidt C.E. Immobilized nerve growth factor and microtopography have distinct effects on polarization versus axon elongation in hippocampal cells in culture. Biomaterials 28 2 (2007) 271-284
109. Yim E.K., and Leong K.W. Proliferation and differentiation of human embryonic germ cell derivatives in bioactive polymeric fibrous scaffold. J. Biomater. Sci., Polym. Ed. 16 10 (2005) 1193-1217
110. Bradbury E.J., Moon L.D., Popat R.J., King V.R., Bennett G.S., Patel P.N., Fawcett J.W., and McMahon S.B. Chondroitinase ABC promotes functional recovery after spinal cord injury. Nature 416 6881 (2002) 636-640
111. Barritt A.W., Davies M., Marchand F., Hartley R., Grist J., Yip P., McMahon S.B., and Bradbury E.J. Chondroitinase ABC promotes sprouting of intact and injured spinal systems after spinal cord injury. J. Neurosci. 26 42 (2006) 10856-10867
112. Kim J.E., Liu B.P., Park J.H., and Strittmatter S.M. Nogo-66 receptor prevents raphespinal and rubrospinal axon regeneration and limits functional recovery from spinal cord injury. Neuron 44 3 (2004) 439-451
113. Li S., and Strittmatter S.M. Delayed systemic Nogo-66 receptor antagonist promotes recovery from spinal cord injury. J. Neurosci. 23 10 (2003) 4219-4227
114. Pearse D.D., Pereira F.C., Marcillo A.E., Bates M.L., Berrocal Y.A., Filbin M.T., and Bunge M.B. cAMP and Schwann cells promote axonal growth and functional recovery after spinal cord injury. Nat. Med. 10 6 (2004) 610-616
115. Lu P., Yang H., Jones L.L., Filbin M.T., and Tuszynski M.H. Combinatorial therapy with neurotrophins and cAMP promotes axonal regeneration beyond sites of spinal cord injury. J. Neurosci. 24 28 (2004) 6402-6409
116. Krause T.L., and Bittner G.D. Rapid morphological fusion of severed myelinated axons by polyethylene glycol. Proc. Natl. Acad. Sci. U. S. A. 87 4 (1990) 1471-1475
117. Lietz M., Ullrich A., Schulte-Eversum C., Oberhoffner S., Fricke C., Muller H.W., and Schlosshauer B. Physical and biological performance of a novel block copolymer nerve guide. Biotechnol. Bioeng. 93 1 (2006) 99-109
118. Mahoney M.J., and Anseth K.S. Three-dimensional growth and function of neural tissue in degradable polyethylene glycol hydrogels. Biomaterials 27 10 (2006) 2265-2274
119. Bryan D.J., Tang J.B., Doherty S.A., Hile D.D., Trantolo D.J., Wise D.L., and Summerhayes I.C. Enhanced peripheral nerve regeneration through a poled bioresorbable poly(lactic-co-glycolic acid) guidance channel. J. Neural Eng. 1 2 (2004) 91-98
120. Evans G.R., Brandt K., Niederbichler A.D., Chauvin P., Herrman S., Bogle M., Otta L., Wang B., and Patrick Jr. C.W. Clinical long-term in vivo evaluation of poly(l-lactic acid) porous conduits for peripheral nerve regeneration. J. Biomater. Sci., Polym. Ed. 11 8 (2000) 869-878
121. Sundback C.A., Shyu J.Y., Wang Y., Faquin W.C., Langer R.S., Vacanti J.P., and Hadlock T.A. Biocompatibility analysis of poly(glycerol sebacate) as a nerve guide material. Biomaterials 26 27 (2005) 5454-5464
122. Widmer M.S., Gupta P.K., Lu L., Meszlenyi R.K., Evans G.R., Brandt K., Savel T., Gurlek A., Patrick Jr. C.W., and Mikos A.G. Manufacture of porous biodegradable polymer conduits by an extrusion process for guided tissue regeneration. Biomaterials 19 21 (1998) 1945-1955
123. Evans G.R., Brandt K., Widmer M.S., Lu L., Meszlenyi R.K., Gupta P.K., Mikos A.G., Hodges J., Williams J., Gurlek A., Nabawi A., Lohman R., and Patrick Jr. C.W. In vivo evaluation of poly(l-lactic acid) porous conduits for peripheral nerve regeneration. Biomaterials 20 12 (1999) 1109-1115
124. Teng Y.D., Lavik E.B., Qu X., Park K.I., Ourednik J., Zurakowski D., Langer R., and Snyder E.Y. Functional recovery following traumatic spinal cord injury mediated by a unique polymer scaffold seeded with neural stem cells. Proc. Natl. Acad. Sci. U. S. A. 99 5 (2002) 3024-3029
125. Hadlock T., Elisseeff J., Langer R., Vacanti J., and Cheney M. A tissue-engineered conduit for peripheral nerve repair. Arch. Otolaryngol. Head Neck Surg. 124 10 (1998) 1081-1086
126. Lesny P., De Croos J., Pradny M., Vacik J., Michalek J., Woerly S., and Sykova E. Polymer hydrogels usable for nervous tissue repair. J. Chem. Neuroanat. 23 4 (2002) 243-247
127. Belkas J.S., Munro C.A., Shoichet M.S., Johnston M., and Midha R. Long-term in vivo biomechanical properties and biocompatibility of poly(2-hydroxyethyl methacrylate-co-methyl methacrylate) nerve conduits. Biomaterials 26 14 (2005) 1741-1749
128. Schmidt C.E., Shastri V.R., Vacanti J.P., and Langer R. Stimulation of neurite outgrowth using an electrically conducting polymer. Proc. Natl. Acad. Sci. U. S. A. 94 17 (1997) 8948-8953
129. Chen S.J., Wang D.Y., Wang X., Zhang P.Y., and Gu X. Template synthesis of the polypyrrole tube and its bridging for sciatic nerve regneration. J. Mater. Sci. Lett. 19 23 (2000) 2157-2159
130. Ikegame M., Tajima K., and Aida T. Template synthesis of polypyrrole nanofibers insulated within one-dimensional silicate channels: hexagonal versus lamellar for recombination of polarons into bipolarons. Angew. Chem., Int. Ed. Engl. 42 19 (2003) 2154-2157
131. Freier T., Montenegro R., Shan Koh H., and Shoichet M.S. Chitin-based tubes for tissue engineering in the nervous system. Biomaterials 26 22 (2005) 4624-4632
132. Guenard V., Valentini R.F., and Aebischer P. Influence of surface texture of polymeric sheets on peripheral nerve regeneration in a two-compartment guidance system. Biomaterials 12 2 (1991) 259-263
133. Zhong Y., Yu X., Gilbert R., and Bellamkonda R.V. Stabilizing electrode-host interfaces: a tissue engineering approach. J. Rehabil. Res. Dev. 38 6 (2001) 627-632
134. Williams L.R. Exogenous fibrin matrix precursors stimulate the temporal progress of nerve regeneration within a silicone chamber. Neurochem. Res. 12 10 (1987) 851-860
135. Williams L.R., Danielsen N., Muller H., and Varon S. Exogenous matrix precursors promote functional nerve regeneration across a 15-mm gap within a silicone chamber in the rat. J. Comp. Neurol. 264 2 (1987) 284-290
136. Hahn S.K., Jelacic S., Maier R.V., Stayton P.S., and Hoffman A.S. Anti-inflammatory drug delivery from hyaluronic acid hydrogels. J. Biomater. Sci., Polym. Ed. 15 9 (2004) 1111-1119
137. Hou S., Tian W., Xu Q., Cui F., Zhang J., Lu Q., and Zhao C. The enhancement of cell adherence and inducement of neurite outgrowth of dorsal root ganglia co-cultured with hyaluronic acid hydrogels modified with Nogo-66 receptor antagonist in vitro. Neuroscience 137 2 (2006) 519-529
138. Hou S., Xu Q., Tian W., Cui F., Cai Q., Ma J., and Lee I.S. The repair of brain lesion by implantation of hyaluronic acid hydrogels modified with laminin. J. Neurosci. Methods 148 1 (2005) 60-70
139. Seckel B.R., Jones D., Hekimian K.J., Wang K.K., Chakalis D.P., and Costas P.D. Hyaluronic acid through a new injectable nerve guide delivery system enhances peripheral nerve regeneration in the rat. J. Neurosci. Res. 40 3 (1995) 318-324
140. Tian W.M., Hou S.P., Ma J., Zhang C.L., Xu Q.Y., Lee I.S., Li H.D., Spector M., and Cui F.Z. Hyaluronic acid-poly-d-lysine-based three-dimensional hydrogel for traumatic brain injury. Tissue Eng. 11 3-4 (2005) 513-525